Teleflex Announces Quarterly Dividend
Get Alerts TFX Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 1%
Revenue Growth %: -38.1%
Join SI Premium – FREE
WAYNE, Pa., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable March 15, 2022, to shareholders of record at the close of business on March 7, 2022. Additional information about Teleflex can be obtained from the company’s website at teleflex.com.
About Teleflex IncorporatedTeleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular access, interventional cardiology and radiology, anesthesia, emergency medicine, surgical, urology and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, QuikClot®, LMA®, Pilling®, Rüsch®, UroLift®, and Weck® – trusted brands united by a common sense of purpose.
Contacts:TeleflexLawrence KeuschVice President, Investor Relations and Strategy Development
John Hsu, CFAVice President, Investor Relations
[email protected]610-948-2836
Source: Teleflex Incorporated
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HTX Earn Winter Campaign: Enjoy APY Boosts on 7 Assets, With a Quota Limit of Up to $14 Million per User
- Axis International files Memorial, maintaining its claim of USD 29 billion arbitration – as Guinea fails to make the first payment due to World Bank Tribunal
- Link Biologics completes IND-enabling preclinical programme for LB001, a first-in-class novel therapy for dry eye disease
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share